Unique pattern of component gene disruption in the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in serous ovarian cancer

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Martinez, Victor D ^a   Vucic, Emily A ^a   Thu, Kelsie L ^a   Pikor, Larissa A ^a   Hubaux, Roland ^a   Lam, Wan L ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CULLIN; CULLIN 3; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MULTIPROTEIN COMPLEX; TRANSCRIPTION FACTOR NRF2; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; CARRIER PROTEIN; CUL3 PROTEIN, HUMAN; KEAP1 PROTEIN, HUMAN; NFE2L2 PROTEIN, HUMAN; RBX1 PROTEIN, HUMAN; REACTIVE OXYGEN METABOLITE; SIGNAL PEPTIDE; UBIQUITIN PROTEIN LIGASE;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; GENE DELETION; GENE DISRUPTION; GENE DOSAGE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; INDEL MUTATION; LOSS OF FUNCTION MUTATION; OVARY CARCINOMA; OXIDATIVE STRESS; PROMOTER REGION; RNA SEQUENCE; ANTAGONISTS AND INHIBITORS; COPY NUMBER VARIATION; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; METABOLISM; MUTATION; OVARY TUMOR;

CARRIER PROTEINS; CULLIN PROTEINS; DNA COPY NUMBER VARIATIONS; DNA METHYLATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTATION; NF-E2-RELATED FACTOR 2; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; REACTIVE OXYGEN SPECIES; UBIQUITIN-PROTEIN LIGASES;

EID: 84904628667     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/159459     Document Type: Article

References (47)

1. Fujii J., Iuchi Y., Okada F., Fundamental roles of reactive oxygen species and protective mechanisms in the female reproductive system. Reproductive Biology and Endocrinology 2005 3, article 43 10.1186/1477-7827-3-43 2-s2.0-27344460746 (Pubitemid 41522393)
2. Nakamura Y., Ohtaki S., Extracellular ATP-induced production of hydrogen peroxide in porcine thyroid cells. Journal of Endocrinology 1990 126 2 283 287 10.1677/joe.0.1260283 2-s2.0-0025309491 (Pubitemid 20227155)
3. Shkolnik K., Tadmor A., Ben-Dor S., Nevo N., Galiani D., Dekel N., Reactive oxygen species are indispensable in ovulation. Proceedings of the National Academy of Sciences of the United States of America 2011 108 4 1462 1467 10.1073/pnas.1017213108 2-s2.0-79952167213
4. Sporn M. B., Liby K. T., NRF2 and cancer: the Good, the bad and the importance of context. Nature Reviews Cancer 2012 12 8 564 571 10.1038/nrc3278 2-s2.0-84864348569
5. Mitsuishi Y., Motohashi H., Yamamoto M., The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism. Frontiers in Oncology 2012 2 article 200 10.3389/fonc.2012.00200
6. Taguchi K., Motohashi H., Yamamoto M., Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes to Cells 2011 16 2 123 140 10.1111/j.1365-2443.2010.01473.x 2-s2.0-78751703950
7. Hayes J. D., McMahon M., NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends in Biochemical Sciences 2009 34 4 176 188 10.1016/j.tibs.2008.12.008 2-s2.0-63549121490
8. Tong K. I., Katoh Y., Kusunoki H., Itoh K., Tanaka T., Yamamoto M., Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model. Molecular and Cellular Biology 2006 26 8 2887 2900 10.1128/MCB.26.8.2887-2900.2006 2-s2.0-33344463325
9. Fukutomi T., Takagi K., Mizushima T., Ohuchi N., Yamamoto M., Kinetic, thermodynamic, and structural characterizations of the association between Nrf2-DLGex degron and Keap1. Molecular and Cellular Biology 2014 34 5 832 846 10.1128/MCB.01191-13
10. Ma Q., Role of Nrf2 in oxidative stress and toxicity. Annual Review of Pharmacology and Toxicology 2013 53 401 426 10.1146/annurev-pharmtox-011112- 140320 2-s2.0-84867034260
11. Dinkova-Kostova A. T., Holtzclaw W. D., Cole R. N., Itoh K., Wakabayashi N., Katoh Y., Yamamoto M., Talalay P., Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proceedings of the National Academy of Sciences of the United States of America 2002 99 18 11908 11913 10.1073/pnas.172398899 2-s2.0-0037015035 (Pubitemid 34994497)
12. Eggler A. L., Liu G., Pezzuto J. M., Van Breemen R. B., Mesecar A. D., Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. Proceedings of the National Academy of Sciences of the United States of America 2005 102 29 10070 10075 10.1073/pnas.0502402102 2-s2.0-22544464124 (Pubitemid 41023327)
13. Baird L., Llères D., Swift S., Dinkova-Kostova A. T., Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex. Proceedings of the National Academy of Sciences of the United States of America 2013 110 38 15259 15264
14. Wakabayashi N., Dinkova-Kostova A. T., Holtzclaw W. D., Kang M., Kobayashi A., Yamamoto M., Kensler T. W., Talalay P., Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proceedings of the National Academy of Sciences of the United States of America 2004 101 7 2040 2045 10.1073/pnas.0307301101 2-s2.0-1242296811 (Pubitemid 38229011)
15. Yamadori T., Ishii Y., Homma S., Morishima Y., Kurishima K., Itoh K., Yamamoto M., Minami Y., Noguchi M., Hizawa N., Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers. Oncogene 2012 31 45 4768 4777 10.1038/onc.2011.628 2-s2.0-84869087891
16. Ma Q., He X., Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2. Pharmacological Reviews 2012 64 4 1055 1081 10.1124/pr.110.004333 2-s2.0-84867041441
17. Kensler T. W., Wakabayashi N., Nrf2: friend or foe for chemoprevention? Carcinogenesis 2009 31 1 90 99 bgp231 10.1093/carcin/bgp231 2-s2.0-74049120454
18. Liao H., Zhou Q., Zhang Z., Wang Q., Sun Y., Yi X., Feng Y., NRF2 is overexpressed in ovarian epithelial carcinoma and is regulated by gonadotrophin and sex-steroid hormones. Oncology Reports 2012 27 6 1918 1924 10.3892/or.2012.1700 2-s2.0-84860708221
19. Kim Y. R., Oh J. E., Kim M. S., Kang M. R., Park S. W., Han J. Y., Eom H. S., Yoo N. J., Lee S. H., Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin. Journal of Pathology 2010 220 4 446 451 10.1002/path.2653 2-s2.0-76749106638
20. Shibata T., Ohta T., Tong K. I., Kokubu A., Odogawa R., Tsuta K., Asamura H., Yamamoto M., Hirohashi S., Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proceedings of the National Academy of Sciences of the United States of America 2008 105 36 13568 13573 10.1073/pnas.0806268105 2-s2.0-51649130168
21. Shibata T., Kokubu A., Gotoh M., Ojima H., Ohta T., Yamamoto M., Hirohashi S., Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology 2008 135 4 1358.e4 1368.e4 10.1053/j.gastro.2008.06.082
22. Nioi P., Nguyen T., A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity. Biochemical and Biophysical Research Communications 2007 362 4 816 821 10.1016/j.bbrc.2007.08.051 2-s2.0-34548577395 (Pubitemid 47390646)
23. Singh A., Misra V., Thimmulappa R. K., Lee H., Ames S., Hoque M. O., Herman J. G., Baylin S. B., Sidransky D., Gabrielson E., Brock M. V., Biswal S., Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Medicine 2006 3 10, article e420 1865 1876 10.1371/journal.pmed.0030420 2-s2.0-33750885385 (Pubitemid 44721825)
24. Thu K. L., Pikor L. A., Chari R., Wilson I. M., MacAulay C. E., English J. C., Tsao M., Gazdar A. F., Lam S., Lam W. L., Lockwood W. W., Genetic disruption of KEAP1/CUL3 E3 ubiquitin ligase complex components is a key mechanism of NF- B pathway activation in lung cancer. Journal of Thoracic Oncology 2011 6 9 1521 1529 10.1097/JTO.0b013e3182289479 2-s2.0-80052268120
25. Zhang D. D., Lo S., Cross J. V., Templeton D. J., Hannink M., Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Molecular and Cellular Biology 2004 24 24 10941 10953 10.1128/MCB.24.24.10941-10953.2004 2-s2.0-10044228504 (Pubitemid 39603148)
26. Kobayashi A., Kang M., Okawa H., Ohtsuji M., Zenke Y., Chiba T., Igarashi K., Yamamoto M., Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Molecular and Cellular Biology 2004 24 16 7130 7139 10.1128/MCB.24.16.7130-7139.2004 2-s2.0-3543008924 (Pubitemid 39014439)
27. Konstantinopoulos P. A., Spentzos D., Fountzilas E., Francoeur N., Sanisetty S., Grammatikos A. P., Hecht J. L., Cannistra S. A., Keap1 mutations and Nrf2 pathway activation in epithelial ovarian cancer. Cancer Research 2011 71 15 5081 5089 10.1158/0008-5472.CAN-10-4668 2-s2.0-79960958309
28. Broad Institute TCGA Genome Data Analysis Center, Analysis Overview for Head and Neck Squamous Cell Carcinoma (Primary Solid Tumor Cohort) 2013
29. Reva B., Antipin Y., Sander C., Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Research 2011 39 17 article e118 10.1093/nar/gkr407 2-s2.0-80053189298
30. Cerami E., Gao J., Dogrusoz U., Gross B. E., Sumer S. O., Aksoy B. A., Jacobsen A., Byrne C. J., Heuer M. L., Larsson E., Antipin Y., Reva B., Goldberg A. P., Sander C., Schultz N., The cBio Cancer Genomics Portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discovery 2012 2 5 401 404 10.1158/2159-8290.CD-12-0095 2-s2.0-84866002291
31. Gao J., Aksoy B. A., Dogrusoz U., Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling 2013 6 269 l1 10.1126/scisignal.2004088
32. Mermel C. H., Schumacher S. E., Hill B., Meyerson M. L., Beroukhim R., Getz G., GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biology 2011 12 4, article R41 10.1186/gb-2011-12-4-r41 2-s2.0-79955166265
33. Reich M., Liefeld T., Gould J., Lerner J., Tamayo P., Mesirov J. P., GenePattern 2.0. Nature Genetics 2006 38 5 500 501 10.1038/ng0506-500 2-s2.0-33646361583
34. Barbie D. A., Tamayo P., Boehm J. S., Kim S. Y., Moody S. E., Dunn I. F., Schinzel A. C., Sandy P., Meylan E., Scholl C., Fröhling S., Chan E. M., Sos M. L., Michel K., Mermel C., Silver S. J., Weir B. A., Reiling J. H., Sheng Q., Gupta P. B., Wadlow R. C., Le H., Hoersch S., Wittner B. S., Ramaswamy S., Livingston D. M., Sabatini D. M., Meyerson M., Thomas R. K., Lander E. S., Mesirov J. P., Root D. E., Gilliland D. G., Jacks T., Hahn W. C., Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 2009 462 7269 108 112 10.1038/nature08460 2-s2.0-70449091786
35. Zhang Z., Wang Q., Ma J., Yi X., Zhu Y., Xi X., Feng Y., Jin Z., AntiReactive oxygen species regulate FSH-induced expression of vascular endothelial growth factor via Nrf2 and HIF1a signaling in human epithelial ovarian cancer. Oncology Reports 2013 29 4 1429 1434 10.3892/or.2013.2278 2-s2.0-84874730539
36. Martinez V. D., Vucic E. A., Pikor L. A., Thu K. L., Hubaux R., Lam W. L., Frequent concerted genetic mechanisms disrupt multiple components of the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in thyroid cancer. Molecular Cancer 2013 12 1, article 124 10.1186/1476-4598-12-124
37. Martinez V. D., Vucic E. A., Thu K. L., Pikor L. A., Lam S., Lam W. L., Disruption of KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex components by multiple genetic mechanisms is associated with poor prognosis in head and neck cancer. Head & Neck 2014 10.1002/hed.23663
38. Poncin S., Colin I. M., Gérard A., Minimal oxidative load: a prerequisite for thyroid cell function. Journal of Endocrinology 2009 201 1 161 167 10.1677/JOE-08-0470 2-s2.0-66849099347
39. Poncin S., van Eeckoudt S., Humblet K., Colin I. M., Gérard A., Oxidative stress: a required condition for thyroid cell proliferation. The American Journal of Pathology 2010 176 3 1355 1363 10.2353/ajpath.2010.090682 2-s2.0-77749273658
40. Hast B. E., Goldfarb D., Mulvaney K. M., Hast M. A., Siesser P. F., Yan F., Hayes D. N., Major M. B., Proteomic analysis of ubiquitin ligase KEAP1 reveals associated proteins that inhibit NRF2 ubiquitination. Cancer Research 2013 73 7 2199 2210 10.1158/0008-5472.CAN-12-4400 2-s2.0-84876011848
41. Geyer R., Wee S., Anderson S., Yates J. III, Wolf D. A., BTB/POZ domain proteins are putative substrate adaptors for cullin 3 ubiquitin ligases. Molecular Cell 2003 12 3 783 790 10.1016/S1097-2765(03)00341-1 2-s2.0-0141750416 (Pubitemid 37222497)
42. Skaar J. R., Pagan J. K., Pagano M., Mechanisms and function of substrate recruitment by F-box proteins. Nature Reviews Molecular Cell Biology 2013 14 6 369 381 10.1038/nrm3582 2-s2.0-84878260314
43. Petroski M. D., Deshaies R. J., Function and regulation of cullin-RING ubiquitin ligases. Nature Reviews Molecular Cell Biology 2005 6 1 9 20 10.1038/nrm1547 2-s2.0-11244351579 (Pubitemid 40064895)
44. Kamura T., Koepp D. M., Conrad M. N., Skowyra D., Moreland R. J., Iliopoulos O., Lane W. S., Kaelin W. G. Jr., Elledge S. J., Conaway R. C., Harper J. W., Conaway J. W., Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science 1999 284 5414 657 661 10.1126/science.284.5414.657 2-s2.0-0033597443 (Pubitemid 29289593)
45. Chowdhry S., Zhang Y., McMahon M., Sutherland C., Cuadrado A., Hayes J. D., Nrf2 is controlled by two distinct β -TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. Oncogene 2013 32 32 3765 3781 10.1038/onc.2012.388 2-s2.0-84881476323
46. Rada P., Rojo A. I., Evrard-Todeschi N., Innamorato N. G., Cotte A., Jaworski T., Tobón-Velasco J. C., Devijver H., García-Mayoral M. F., Van Leuven F., Hayes J. D., Bertho G., Cuadrado A., Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/ β -TrCP axis. Molecular and Cellular Biology 2012 32 17 3486 3499 10.1128/MCB.00180-12 2-s2.0-84866283856
47. Verhaak R. G., Tamayo P., Yang J. Y., Prognostically relevant gene signatures of high-grade serous ovarian carcinoma. Journal of Clinical Investigation 2013 123 1 517 525 10.1172/JCI65833